Lytgobi 64842-0120-05
Generic: Futibatinib
- Manufacturer
- Taiho Pharmaceutical Co., Ltd.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 3, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA214801
Need to source Lytgobi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Futibatinib | 4 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Fibroblast Growth Factor Receptor Inhibitors [MoA]
Selected Package
64842-0120-05Selected1 BLISTER PACK in 1 CARTON (64842-0120-5) / 28 TABLET in 1 BLISTER PACK
Other packages for this product(2)
1 BLISTER PACK in 1 CARTON (64842-0120-4) / 21 TABLET in 1 BLISTER PACK
1 BLISTER PACK in 1 CARTON (64842-0120-6) / 35 TABLET in 1 BLISTER PACK